[1] |
ZHENG Hong, CHEN Xiaoxia, HAN Lizhou, CHEN Miao, HUANGFU Juan.
Decrease of lncRNA-RMRP expression inhibits proliferation and invasion of human lung cancer cell line A549
[J]. Basic & Clinical Medicine, 2024, 44(7): 974-978.
|
[2] |
CAO Qingwen, QI Lin, YU Bo, TIAN Chenchen, YUAN Haining, WANG Yue.
Salidroside promotes proliferation and migration of human vascular endothelial cell line EA.hy926
[J]. Basic & Clinical Medicine, 2024, 44(7): 925-930.
|
[3] |
CAO Chenxin, TANG Hui, GENG Ruixuan, GUO Fuping, BAI Chunmei, WANG Yingyi, LI Taisheng.
Correlation between circulating CD4+CD45RA+CD62L+ T cells and prognosis of metastatic non-small cell lung cancer treated with EGFR-TKI
[J]. Basic & Clinical Medicine, 2024, 44(5): 658-664.
|
[4] |
JIA Anna, GUO Jinxin, ZHANG Xuan, ZHAN Shijia, YU Yongbo, GUO Yongli, CHANG Yan.
Regulation of TMEFF1 on proliferation of neuroblastoma cell lines
[J]. Basic & Clinical Medicine, 2024, 44(5): 637-644.
|
[5] |
SONG Ke, SONG Ke, LI Jingyu, MA Wei, YANG Xiaokui.
Protein expression and subcellular distribution of centriolar component SAS-6 in mouse oocyte meiosis
[J]. Basic & Clinical Medicine, 2024, 44(5): 651-657.
|
[6] |
LIANG Xiangcun, WEI Xiaoyu, LIANG Jian, WANG Qing, GENG Guang.
Anlotinib inhibits proliferation and promotes apoptosis of human non-small cell lung cancer cell lines through miR-16-5p/PD-1 axis
[J]. Basic & Clinical Medicine, 2024, 44(4): 503-512.
|
[7] |
LU Kai, LU Jianju, GUO Wenli, HUANG Jianqi, LI Zhihua.
lncRNA VIM-AS5 expression and its effect on proliferation and migration of human breast cancer cell lines
[J]. Basic & Clinical Medicine, 2024, 44(4): 447-453.
|
[8] |
ZHANG Jing, YANG Zigeng, CAI Wenqin, CAO Weiwei, WEI Hongmei, XUE Xixi, WU Bin.
Inhibition of prohibitin 2 enhances the sensitivity of non-small cell lung cancer cell line A549 to erlotinib
[J]. Basic & Clinical Medicine, 2024, 44(3): 325-332.
|
[9] |
LI Juan, LI Xiaofeng, XU Shengzhi, TANG Kai.
Efficacy of cinobufacini capsule combined with docetaxel plus cisplatin chemotherapy for the treatment of non-small cell lung cancer
[J]. Basic & Clinical Medicine, 2024, 44(2): 247-251.
|
[10] |
FANG Yuan, LI Yi, WANG Wei.
CircRERE promotes proliferation, migration and invasion of human multiple myeloma cell lines by regulating miR-128-3p/WEE1 axis
[J]. Basic & Clinical Medicine, 2024, 44(2): 210-218.
|
[11] |
DING Fei, WANG Sa, HUANG Changxin.
Serum CA211 level and NK cell number are associated with prognosis of patients with non-small cell lung cancer
[J]. Basic & Clinical Medicine, 2024, 44(2): 180-184.
|
[12] |
.
Association of seven antibody levels in lung cancer with chemotherapy effect and prognosis in patients with NSCLC
[J]. Basic & Clinical Medicine, 2024, 44(10): 1383-1387.
|
[13] |
LI Jiangli, SUN Jing, TANG Yijun, GUO Junlan, CHEN Bo, GUO Shengnan.
Circ-DDX5 inhibits the proliferation and invasion of human breast cancer cell lines by targeting miR-3940
[J]. Basic & Clinical Medicine, 2024, 44(1): 1-7.
|
[14] |
YAN Chenhong, JIN Er.
Progress of exosomal PD-L1 in diagnosis and treatment of non-small cell lung cancer
[J]. Basic & Clinical Medicine, 2023, 43(9): 1457-1461.
|
[15] |
ZHANG Xiaowan, KANG Xia, YAO Xiaoying, XIE Fang, LI Ying.
Silencing SF3B1 promotes apoptosis and inhibits proliferation and invasion of human lung cancer cell line A549
[J]. Basic & Clinical Medicine, 2023, 43(8): 1265-1270.
|